Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells (Q47974235)

7 February 2018

title

Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells (English)

1 reference

7 February 2018

author name string

M E Stearns

series ordinal

1

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

Clinical & Experimental Metastasis

published in

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

332-339

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1006513413583

exact match

0 references

cites work

Stimulation of the differentiation of osteogenic rat bone marrow stromal cells by osteoblast cultures

1 reference

12 December 2020

Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice

1 reference

12 December 2020

Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.

1 reference

12 December 2020

Bisphosphonates: mechanisms of action

1 reference

12 December 2020

New bisphosphonates in the treatment of bone metastases

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression

1 reference

12 December 2020

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment

1 reference

12 December 2020

Mouse osteoblasts synthesize collagenase in response to bone resorbing agents

1 reference

12 December 2020

The relationship of collagenolytic activity to stage of human colorectal carcinoma

1 reference

12 December 2020

Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC-3.

1 reference

12 December 2020

Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products

1 reference

12 December 2020

Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue

1 reference

12 December 2020

Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions

1 reference

12 December 2020

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro

1 reference

12 December 2020

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

1 reference

12 December 2020

Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice

1 reference

12 December 2020

Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen

1 reference

12 December 2020

Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases

1 reference

12 December 2020

Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice

1 reference

12 December 2020

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

1 reference

12 December 2020

Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system.

1 reference

12 December 2020

Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours

1 reference

12 December 2020

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

1 reference

12 December 2020

Diphosphonate Therapy of Paget's Disease of Bone

1 reference

12 December 2020

Generation of osteoclasts in cultures of rabbit bone marrow and spleen cells

1 reference

12 December 2020

Diphosphonates in Paget's disease

1 reference

12 December 2020

Synthesis of collagenase and collagenase inhibitors by osteoblast-like cells in culture

1 reference

12 December 2020

Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma

1 reference

12 December 2020

Bone resorption by isolated osteoclasts in living versus devitalized bone: differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases

1 reference

12 December 2020

Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines

1 reference

12 December 2020

Production of both 92- and 72-kDa gelatinases by bone cells

1 reference

12 December 2020

Mechanisms of cancer metastasis to bone

1 reference

12 December 2020

Diphosphonates and Page's disease of bone.

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.

1 reference

12 December 2020

Clodronate for osteolytic metastases due to breast cancer

1 reference

12 December 2020

Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat

1 reference

12 December 2020

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

1 reference

12 December 2020

Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression

1 reference

12 December 2020

Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis

1 reference

12 December 2020

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

1 reference

12 December 2020

Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue

1 reference

12 December 2020

Molecular mechanisms of bone resorption. An update.

1 reference

12 December 2020

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

12 December 2020

Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006513413583

1 reference

7 February 2018

Dimensions Publication ID

0 references

1 reference

7 February 2018